The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is one drug that's now approved it's called I think I'm going to get the name wrong it's like set MTI or something like this um it's an mc4 receptor Agonist um it's mainly used relatively small populations of people that for example have mutations in this pathway it's not used as a widespread as as as a drug and the challenge has been um really side effects
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.